Search research articles
Contact Us
Filters
Showing results (71-80 of 147) with videos related to
Page
of 15
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
November 17, 2023
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
Kerstin Hofstetter, Julian Taugner, Lukas Käsmann, et al.
Anticancer Research
|
September 15, 2019
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment
Lukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
Translational Lung Cancer Research
|
November 19, 2019
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy
Julian Taugner, Lukas Käsmann, Chukwuka Eze, et al.
Journal of Cancer Research and Clinical Oncology
|
August 1, 2022
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
Benedikt Flörsch, Julian Taugner, Lukas Käsmann, et al.
Oncology Research and Treatment
|
April 9, 2020
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations
Diego Kauffmann-Guerrero, Amanda Tufman, Kathrin Kahnert, et al.
Frontiers in Immunology
|
July 14, 2022
Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC
Laura Sellmer, Julia Kovács, Julia Walter, et al.
Oncology Research and Treatment
|
March 25, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies
Fabian Acker, Jingting Luan, Puyan Soltani Germy, et al.
Oncology Research and Treatment
|
April 4, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers
Marcel Kemper, Puyan Soltani Germy, Fabian Acker, et al.
Cancers
|
December 11, 2025
Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany
Blerina Resuli, Julia Walter, Diego Kauffmann-Guerrero, et al.
Endocrine
|
February 2, 2018
IGF-1-based screening reveals a low prevalence of acromegaly in patients with obstructive sleep apnea
Daniel A Heinrich, Claudia Reinholz, Maximilian Bauer, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 147) with videos related to
Sort By:
Page
of 15
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
November 17, 2023
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
Kerstin Hofstetter, Julian Taugner, Lukas Käsmann, et al.
Anticancer Research
|
September 15, 2019
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment
Lukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
Translational Lung Cancer Research
|
November 19, 2019
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy
Julian Taugner, Lukas Käsmann, Chukwuka Eze, et al.
Journal of Cancer Research and Clinical Oncology
|
August 1, 2022
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
Benedikt Flörsch, Julian Taugner, Lukas Käsmann, et al.
Oncology Research and Treatment
|
April 9, 2020
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations
Diego Kauffmann-Guerrero, Amanda Tufman, Kathrin Kahnert, et al.
Frontiers in Immunology
|
July 14, 2022
Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC
Laura Sellmer, Julia Kovács, Julia Walter, et al.
Oncology Research and Treatment
|
March 25, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies
Fabian Acker, Jingting Luan, Puyan Soltani Germy, et al.
Oncology Research and Treatment
|
April 4, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers
Marcel Kemper, Puyan Soltani Germy, Fabian Acker, et al.
Cancers
|
December 11, 2025
Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany
Blerina Resuli, Julia Walter, Diego Kauffmann-Guerrero, et al.
Endocrine
|
February 2, 2018
IGF-1-based screening reveals a low prevalence of acromegaly in patients with obstructive sleep apnea
Daniel A Heinrich, Claudia Reinholz, Maximilian Bauer, et al.
Page
of 15